Abstract
This study compared troponin I (cTnI) to troponin T (cTnT) in a population admitted to General Medicine Divisions in whom acute myocardial infarction (AMI) was suspected; 98 consecutive patients were included. Diagnoses were made without knowledge of troponin results: 51 patients had AMI, and 47 (including 8 with unstable angina) had no AMI. Patients were considered to be troponin positive if the marker concentration was >99th percentile value of the reference population. Both troponins were associated with an almost absolute sensitivity for AMI (100% for cTnI and 98.0% for cTnT), while the specificity was marginally higher for cTnI (78.7% vs. 68.1%). Increased cTnI and/or cTnT were observed in 15 patients out of 39 without acute coronary syndromes. Simultaneous positivity was seen in 8 patients with severe disorders and complications. Discordances were more frequent in favor of increased cTnT (n = 5) than the opposite (n = 2), even if this difference did not achieve statistical significance. cTnI and cTnT detected AMI with comparable efficiency. Cases without coronary syndrome positively concordant for troponins confirmed the ability of these biomarkers to detect myocardial injury undetectable by conventional diagnostic approaches. J. Clin. Lab. Anal. 15:210–214, 2001. © 2001 Wiley‐Liss, Inc.
Keywords: diagnosis, laboratory; myocardial infarction; sensitivity and specificity; troponin
REFERENCES
- 1. Panteghini M, Apple FS, Christenson RH, Dati F, Mair J, Wu AH. 1999. Use of biochemical markers in acute coronary syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. Clin Chem Lab Med 37:687–693. [DOI] [PubMed] [Google Scholar]
- 2. The Joint European Society of Cardiology/American College of Cardiology Committee . 2000. Myocardial infarction redefined—a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36:959–969. [DOI] [PubMed] [Google Scholar]
- 3. Panteghini M. 1999. Biochemical assessment of myocardial damage with new diagnostic tools. Cardiologia 44:419–425. [PubMed] [Google Scholar]
- 4. Chapelle JP. 1999. Cardiac troponin I and T: recent players in the field of myocardial markers. Clin Chem Lab Med 37:11–20. [DOI] [PubMed] [Google Scholar]
- 5. Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, Galvani M, Katus H. 2000. It’s time for a change to a troponin standard. Circulation 102:1216–1220. [DOI] [PubMed] [Google Scholar]
- 6. Hillis GS, Fox KAA. 1999. Cardiac troponins in chest pain. Can help in risk stratification. Br Med J 319:1451–1452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Hetland O, Dickstein K. 1998. Cardiac troponin I and T in patients with suspected acute coronary syndrome: a comparative study in a routine setting. Clin Chem 44:1430–1436. [PubMed] [Google Scholar]
- 8. Panteghini M. 1998. Clinical and analytical performance of automated immunochemiluminometric assays for determination of cardiac markers in serum. J Biolumin Chemilumin 13:307–309. [DOI] [PubMed] [Google Scholar]
- 9. Muller‐Bardorff M, Hallermayer K, Schroder A, Ebert C, Borgya A, Gerhardt W, et al. 1997. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem 43:458–466. [PubMed] [Google Scholar]
- 10. Pagani F, Bonetti G, Panteghini M. 1999. A comparative study of cardiac troponin I and troponin T release in the early phase after myocardial infarction. Clin Chem 45:A143–A144. [Google Scholar]
- 11. Panteghini M, Bonora R, Pagani F, Buffoli F, Cuccia C. 1997. Rapid, highly sensitive immunoassay for determination of cardiac troponin I in patients with myocardial cell damage. Clin Chem 43:1464–1465. [PubMed] [Google Scholar]
- 12. Panteghini M, Pagani F, Bonetti G. 1999. The sensitivity of cardiac markers: an evidence‐based approach. Clin Chem Lab Med 37:1097–1106. [DOI] [PubMed] [Google Scholar]
- 13. Missov E, Calzolari C, Pau B. 1997. Circulating cardiac troponin I in severe congestive heart failure. Circulation 96:2953–2958. [DOI] [PubMed] [Google Scholar]
- 14. Missov E, Mair J. 1999. A novel biomedical approach to congestive heart failure: cardiac troponin T. Am Heart J 138:95–99. [DOI] [PubMed] [Google Scholar]
- 15. Ooi DS, Isotalo PA, Veinot JP. 2000. Correlation of antemortem serum creatine kinase, creatine kinase‐MB, troponin I, and troponin T with cardiac pathology. Clin Chem 46:338–344. [PubMed] [Google Scholar]
- 16. McLaurin MD, Apple FS, Voss EM, Herzog CA, Sharkey SW. 1997. Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle. Clin Chem 43:976–982. [PubMed] [Google Scholar]
- 17. Ricchiuti V, Voss EM, Ney A, Odland M, Anderson PAW, Apple FS. 1998. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false‐positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem 44:1919–1924. [PubMed] [Google Scholar]
- 18. Jaffe AS. 1999. 2001—A biomarker odyssey. Clin Chim Acta 284:197–211. [DOI] [PubMed] [Google Scholar]
- 19. Bock JL. 1999. Cardiac troponin. How specific is specific? Am J Clin Pathol 112:739–741. [DOI] [PubMed] [Google Scholar]
- 20. Jaffe AS. 1999. Pandora’s box is torn asunder. Am Heart J 138:9–12. [DOI] [PubMed] [Google Scholar]